Summary

Biotech, Symbiont engineering, living medicine, living drug, organism design, rare orphan diseases, biologics, human performance, health, symbiont design, biotechnology, delivery platform, Research & Development

Description

Unlike popular experimental solutions to the biologics problem based on engineering bacteria, fungi, or viruses, Simmbionโ€™s core technology is based on the synthetic modification of naturally occurring symbionts that safely inhabit millions of people across the globe. Our core technology will engineer symbionts to produce therapeutic agents while avoiding dangerous infections or immune rejection. This will supplant the need for complex manufacturing, repeated injections, long hours of infusions, temperature sensitive storage, high cost of care, and associated compliance issues in a patient-centric, value, and outcome driven healthcare model.

Special details

organism culturing, animal models, pre-clinical models, genetic engineering,

Profile

  • Incorporated in
    Delaware
  • Established since
    2017
  • Main/Branch
    Branch

Address

Contact